N-(3-Chloro-4-fluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACBNGV951
CAS No. :
1775442-36-8
Molecular Formula :
C21H21ClFN3O2
Molecular Weight :
401.87

IUPAC Name:N-(3-chloro-4-fluorophenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

N-(3-Chloro-4-fluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Chloro-4-fluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(3-chloro-4-fluorophenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
Molecular FormulaC21H21ClFN3O2
Molecular Weight401.87
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC=C(F)C(Cl)=C4
InChI KeyDPJUHSBHEHYCAU-UHFFFAOYSA-N
SynonymN-(3-chloro-4-fluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, N-(3-chloro-4-fluorophenyl)-5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-
CAS No.1775442-36-8

Synthetic Route by SureRoute

1. ACBNGV951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBNGV951 route product structure diagram
    ACBNGV9511775442-36-8
Inquiry

2. ACBNGV951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBNGV951 route product structure diagram
    ACBNGV9511775442-36-8
Inquiry

Comments (0)